Similar to low-grade glioma, in which the S100A family genes play vital roles in tumor progression mostly via the IL-17 signaling pathway [36], our data implied that S100A2 might play a critical role in endometrial carcinoma initiation and progression through similar mechanisms. This evidence concerns the gene IL17A and central nervous system cancer.